|
Green Cross Corporation (æ ªå¼?会社ミドリå??å—; Kabushiki Gaisha Midori JÅ«ji) was one of a premire pharmaceutical companies in Japan. A company merged into Yoshitomi Pharmaceutical Co., Ltd. (å?‰å¯Œè£½è–¬æ ªå¼?会社) on April 1, 1998, and renamed to Welfide Corporation (ã‚¦ã‚§ãƒ«ãƒ•ã‚¡ã‚¤ãƒ‰æ ªå¼?会社) in 2000. Eventually Welfide Corp. & Mitsubishi-Tokyo Pharmaceutical Inc. (三è?±æ?±äº¬è£½è–¬æ ªå¼?会社) were mereged to form Mitsubishi Pharma Corporation (三è?±ã‚¦ã‚§ãƒ«ãƒ•ã‚¡ãƒ¼ãƒžæ ªå¼?会社) on October 1, 2001.
Green Cross was founded around 1950 as Japan's first commercial blood bank & became a diversified international pharma producing prescription medicine for even delivery or administration by doctors and health care workers.
It involved war felon like Kitano Masaji world health organization performed mortal experimentation inside Unit 731 of the Japanese military in the period of World War II.
Its products were extensively utilized in the treatments of the wide range of ill. Too when supplying totally blood for transfusions, Green Cross was likewise active within getting blood derivative products like clotting factor, immunoglobulin and albumin. In the mid 1960's, it expanded into the non-plasma sector. Cardiovascular agencies, coagulation/fibrinolytic agencies, immunologic offices, anti-anti-inflammatory drug professionals, albumin-depending professionals, blood plasma components & parenteral nutrition accounted for 71% of fiscal 1998 unconsolidated revenues; wholesale of symptomatic reagents, 14% & more, 15%. Unconsolidated revenues accounted for 59.5% of fiscal 1998 consolidated revenues. A company experienced eleven consolidated subsidiaries, tierce every in the United States and Japan, and a single every within Germany, the United Kingdom, Barbados, China and Hong Kong. Overseas sales accounted for 41.9% of fiscal 1998 consolidated revenues.
|